VANCOUVER--(BUSINESS WIRE)--LifeSciences British Columbia today announced that it has entered into a Memorandum of Understanding with the GyeongGi Bio-Center, a non-profit organization responsible for supporting the biotech and pharmaceutical industries in Korea’s GyeongGi Province, in order to facilitate partnership and collaboration between the two province’s biotech and life sciences industries.
Karimah Es Sabar, President of LifeSciences BC commented that, “Strong global partnerships are essential to the development of our industry locally. Korea, and specifically the GyeongGi Bio-Center (GGBC) is home to a cluster of leading international companies and research institutions, and both BC and Korea have much to gain through our working together.”
The MOU notes that the prospects for pharmaceutical and life sciences industry and technology development cooperation between the GyeongGi Province and British Columbia are excellent, and promise substantial mutual benefit based on the complementary structure for economic and R&D development of the two parties’ countries.
British Columbia and GyeongGi Province successfully reached a Sister Province Relationship on May 19, 2008 that enhances understanding and cooperation between the two jurisdictions. Both LifeSciences BC and GGBC support the GyeongGi-British Columbia Sister Province Relationship as a platform to strengthen mutual collaboration for the benefit our respective life sciences industries.
“This collaboration is a great example of the partnerships that our province is building at home and abroad,” said Iain Black, British Columbia’s minister of Small Business, Technology and Economic Development. “I congratulate LifeSciences BC and the GyeongGi Bio-Center on this agreement, which will strengthen the biotech and life sciences industries in both provinces.”
About LifeSciences BC:
LifeSciences British Columbia supports and represents the biopharmaceutical, medical device, bioproducts, bioenergy and greater life sciences community of British Columbia through leadership, advocacy and promotion of our world-class science and industry. Via active facilitation of partnering and investment into the life sciences sector, British Columbia is fast becoming a global life sciences leader. LifeSciences British Columbia is a not-for-profit, non-government, industry-funded association.
Angiotech Pharmaceuticals, Inc.
Cardiome Pharma Corp.
Ernst & Young
Farris, Vaughan, Wills & Murphy LLP
Genome British Columbia
LifeScan Canada Ltd.
McCarthy Tétrault LLP
Pfizer Canada Inc.
Rx&D, Canada's Research-Based Pharmaceutical Companies
Business in Vancouver
Gowling Lafleur Henderson LLP
Hoffmann-La Roche Ltd.
Technology Vision Group LLC
The Vancouver Economic Development Commission
Aon Reed Stenhouse
BC Bioenergy Network
Bull, Housser & Tupper LLP
Centre for Drug Research & Development
Fasken Martineau LLP
UBC University-Industry Liaison Office